Dual-function injectable fibrin gel incorporated with sulfated chitosan nanoparticles for rhBMP-2-induced bone regeneration
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Connective tissue disorders research · Heterotopic Ossification and Related Conditions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Health-related quality of life in older people with osteoporotic vertebral fractures: clinically important vs. statistically significant10.1007/s00198-016-3725-1 ↗
2. Targeting skeletal endothelium to ameliorate bone loss10.1038/s41591-018-0020-z ↗
3. Bench-to-bedside strategies for osteoporotic fracture: from osteoimmunology to mechanosensation10.1038/s41413-019-0066-7 ↗
4. The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats10.1016/j.biomaterials.2012.03.069 ↗
5. Minimally invasive and regenerative therapeutics
6. A minimally invasive exosome spray repairs heart after myocardial infarction10.1021/acsnano.1c00628 ↗
7. Inflammatory response in postmenopausal osteoporotic fracture healing10.1302/2046-3758.97.BJR-2019-0300.R2 ↗
8. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty10.1038/s41569-018-0064-2 ↗
9. A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein-2 and zoledronic acid10.1126/sciadv.abc1779 ↗
10. rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics
11. Safety profile for the clinical use of bone morphogenetic proteins in the spine10.1097/00007632-200208151-00010 ↗
12. Sustained BMP-2 delivery and injectable bone regeneration using thermosensitive polymeric nanoparticle hydrogel bearing dual interactions with BMP-210.1016/j.jconrel.2015.04.023 ↗
13. Inflammatory response to recombinant human bone morphogenetic protein-2 use in the treatment of a proximal humeral fracture: a case report10.1016/j.jse.2011.06.006 ↗
14. Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model10.1097/BRS.0b013e3181f2d1ec ↗
15. High-dose bone morphogenetic protein-induced ectopic abdomen bone growth10.1016/j.spinee.2009.10.016 ↗
16. Enhanced mandibular bone repair by combined treatment of bone morphogenetic protein 2 and small-molecule Phenamil10.1089/ten.tea.2016.0308 ↗
17. A review of the clinical side effects of bone morphogenetic protein-210.1089/ten.teb.2015.0357 ↗
18. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-210.1016/j.actbio.2008.04.002 ↗
19. Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-210.1016/j.biomaterials.2012.05.030 ↗
20. Delivering on the promise of bone morphogenetic proteins10.1016/S0167-7799(01)01665-1 ↗
21. Regulation of macrophage polarization through surface topography design to facilitate implant-to-bone osteointegration10.1126/sciadv.abf6654 ↗
22. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity10.1111/j.1432-1033.1996.0295n.x ↗
23. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins10.1074/jbc.M300937200 ↗
24. Affinity-selected polysaccharide for rhBMP-2-induced osteogenesis via BMP receptor activation
25. Tuning the bioactivity of bone morphogenetic protein-2 with surface immobilization strategies10.1016/j.actbio.2018.09.011 ↗
26. Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan10.1016/j.actbio.2018.02.031 ↗
27. Sulfated polysaccharide directs therapeutic angiogenesis via endogenous VEGF secretion of macrophages10.1126/sciadv.abd8217 ↗
28. Enhancement and orchestration of osteogenesis and angiogenesis by a dual-modular design of growth factors delivery scaffolds and 26SCS decoration10.1016/j.biomaterials.2019.119645 ↗
29. Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorporating BMP-210.1016/j.biomaterials.2013.10.005 ↗
30. Bone regeneration using photocrosslinked hydrogel incorporating rhBMP-2 loaded 2-N, 6-O-sulfated chitosan nanoparticles10.1016/j.biomaterials.2013.12.028 ↗
31. 2-N, 6-O-sulfated chitosan-assisted BMP-2 immobilization of PCL scaffolds for enhanced osteoinduction10.1016/j.msec.2016.12.004 ↗
32. The multifaceted role of fibrinogen in tissue injury and inflammation10.1182/blood-2018-07-818211 ↗
33. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo10.1016/j.biomaterials.2008.12.016 ↗
34. The generation of closed femoral fractures in mice: a model to study bone healing
35. Optimization of a closed rat tibial fracture model10.1186/s40634-018-0128-6 ↗
36. Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts10.1172/JCI69443 ↗
37. Heparin microislands in microporous annealed particle scaffolds for accelerated diabetic wound healing
38. Fibrinogen-based hydrogel modulus and ligand density effects on cell morphogenesis in two-dimensional and three-dimensional cell cultures10.1002/adhm.201801436 ↗
39. Fibrin gel suspended autologous chondrocytes as cell-based material for long-term injection Laryngoplasty
40. Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts10.2319/050210-238.1 ↗
41. Differentiation of preosteoblasts is affected by implant surface microtopographies10.1002/jbm.a.30016 ↗
42. Osteoimmunology: interactions of the Immune and Skeletal Systems
43. Fibrinogen scaffolds with immunomodulatory properties promote in vivo bone regeneration10.1016/j.biomaterials.2016.10.004 ↗
44. Fracture healing under healthy and inflammatory conditions10.1038/nrrheum.2012.1 ↗
45. In situ regulation of macrophage polarization to enhance osseointegration under diabetic conditions using injectable silk/sitagliptin gel scaffolds
46. Enhanced angiogenesis and osteogenesis in critical bone defects by the controlled release of BMP-2 and VEGF: implantation of electron beam melting-fabricated porous Ti6Al4V scaffolds incorporating growth factor-doped fibrin glue10.1088/1748-6041/10/3/035013 ↗
47. Recombinant human bone morphogenetic protein-2 suspended in fibrin glue enhances bone formation during distraction osteogenesis in rabbits10.5114/aoms.2016.59922 ↗
48. Macrophages and skeletal health10.1016/j.pharmthera.2017.02.017 ↗
49. Osteoporotic conditions influence the activity of adipose-derived stem cells10.1007/s13770-020-00289-x ↗
50. Treatment with a long-acting chimeric CSF1 molecule enhances fracture healing of healthy and osteoporotic bones10.1016/j.biomaterials.2021.120936 ↗